Yokota T et al. |
Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter. |
2004 |
Oncogene |
pmid:15107822
|
Suzuki M et al. |
Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b. |
2006 |
Oncogene |
pmid:16331260
|
McGarry LC et al. |
Invasion of v-Fos(FBR)-transformed cells is dependent upon histone deacetylase activity and suppression of histone deacetylase regulated genes. |
2004 |
Oncogene |
pmid:15107823
|
Guo WH et al. |
Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor. |
2002 |
Oncogene |
pmid:12447699
|
Ong DC et al. |
LARG at chromosome 11q23 has functional characteristics of a tumor suppressor in human breast and colorectal cancer. |
2009 |
Oncogene |
pmid:19734946
|
Tessema M et al. |
Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis. |
2010 |
Oncogene |
pmid:20562917
|
Vincent A et al. |
Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells. |
2007 |
Oncogene |
pmid:17471237
|
Wong CH et al. |
CTSL2 is a pro-apoptotic target of E2F1 and a modulator of histone deacetylase inhibitor and DNA damage-induced apoptosis. |
2014 |
Oncogene |
pmid:23542171
|
Augenlicht L et al. |
Repression of MUC2 gene expression by butyrate, a physiological regulator of intestinal cell maturation. |
2003 |
Oncogene |
pmid:12902981
|
Gurova KV et al. |
Expression of prostate specific antigen (PSA) is negatively regulated by p53. |
2002 |
Oncogene |
pmid:11791186
|
Zhong S et al. |
Phosphorylation at serine 28 and acetylation at lysine 9 of histone H3 induced by trichostatin A. |
2003 |
Oncogene |
pmid:12917630
|
Futamura M et al. |
Trichostatin A inhibits both ras-induced neurite outgrowth of PC12 cells and morphological transformation of NIH3T3 cells. |
1995 |
Oncogene |
pmid:7700637
|
Hajji N et al. |
Combinatorial action of the HDAC inhibitor trichostatin A and etoposide induces caspase-mediated AIF-dependent apoptotic cell death in non-small cell lung carcinoma cells. |
2008 |
Oncogene |
pmid:18071312
|
Mühlisch J et al. |
Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood. |
2006 |
Oncogene |
pmid:16186793
|
Cismasiu VB et al. |
BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter. |
2005 |
Oncogene |
pmid:16091750
|
Karagiannis TC et al. |
Disparity of histone deacetylase inhibition on repair of radiation-induced DNA damage on euchromatin and constitutive heterochromatin compartments. |
2007 |
Oncogene |
pmid:17213813
|
Sengupta S et al. |
Tumor suppressor p53 represses transcription of RECQ4 helicase. |
2005 |
Oncogene |
pmid:15674334
|
Busson M et al. |
Coactivation of nuclear receptors and myogenic factors induces the major BTG1 influence on muscle differentiation. |
2005 |
Oncogene |
pmid:15674337
|
Sengupta S et al. |
Human AP endonuclease (APE1/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1. |
2011 |
Oncogene |
pmid:20856196
|
Fleury L et al. |
Eliminating epigenetic barriers induces transient hormone-regulated gene expression in estrogen receptor negative breast cancer cells. |
2008 |
Oncogene |
pmid:18317449
|
Shin HJ et al. |
Inhibition of histone deacetylase activity increases chromosomal instability by the aberrant regulation of mitotic checkpoint activation. |
2003 |
Oncogene |
pmid:12813458
|
Kim TY et al. |
Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells. |
2003 |
Oncogene |
pmid:12813468
|
Krishnan M et al. |
HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability. |
2010 |
Oncogene |
pmid:19881542
|
Shteper PJ et al. |
Role of promoter methylation in regulation of the mammalian heparanase gene. |
2003 |
Oncogene |
pmid:14586400
|
Hirose T et al. |
p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y. |
2003 |
Oncogene |
pmid:14586402
|
Vaghefi H and Neet KE |
Deacetylation of p53 after nerve growth factor treatment in PC12 cells as a post-translational modification mechanism of neurotrophin-induced tumor suppressor activation. |
2004 |
Oncogene |
pmid:15361854
|
Zubia A et al. |
Identification of (1H)-pyrroles as histone deacetylase inhibitors with antitumoral activity. |
2009 |
Oncogene |
pmid:19169274
|
Sato N et al. |
Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma. |
2005 |
Oncogene |
pmid:15592528
|
Kumar KS et al. |
Histone deacetylase inhibitors induce cell death in supratentorial primitive neuroectodermal tumor cells. |
2006 |
Oncol. Rep. |
pmid:17016591
|
Kang FW et al. |
Effects of trichostatin A on HIF-1α and VEGF expression in human tongue squamous cell carcinoma cells in vitro. |
2012 |
Oncol. Rep. |
pmid:22552321
|
Meng J et al. |
The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways. |
2012 |
Oncol. Rep. |
pmid:22552631
|
Rhodes LV et al. |
The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells. |
2012 |
Oncol. Rep. |
pmid:21971930
|
Kim SH et al. |
Regulation of the HIF-1alpha stability by histone deacetylases. |
2007 |
Oncol. Rep. |
pmid:17273746
|
Anh TD et al. |
The histone deacetylase inhibitor, Trichostatin A, induces G2/M phase arrest and apoptosis in YD-10B oral squamous carcinoma cells. |
2012 |
Oncol. Rep. |
pmid:21993600
|
Ganslmayer M et al. |
A quadruple therapy synergistically blocks proliferation and promotes apoptosis of hepatoma cells. |
2004 |
Oncol. Rep. |
pmid:15069530
|
Ma X et al. |
Effect of LIV1 on the sensitivity of ovarian cancer cells to trichostatin A. |
2015 |
Oncol. Rep. |
pmid:25420545
|
Wang B et al. |
Reversion of trichostatin A resistance via inhibition of the Wnt signaling pathway in human pancreatic cancer cells. |
2014 |
Oncol. Rep. |
pmid:25224651
|
Wang JH et al. |
HDAC inhibitors, trichostatin A and valproic acid, increase E‑cadherin and vimentin expression but inhibit migration and invasion of cholangiocarcinoma cells. |
2018 |
Oncol. Rep. |
pmid:29767267
|
Zhang X et al. |
Tyrphostin B42 attenuates trichostatin A-mediated resistance in pancreatic cancer cells by antagonizing IL-6/JAK2/STAT3 signaling. |
2018 |
Oncol. Rep. |
pmid:29393444
|
Ji M et al. |
HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells. |
2015 |
Oncol. Rep. |
pmid:25813246
|
Um SJ et al. |
In vitro antitumor potential of 4-BPRE, a butyryl aminophenyl ester of retinoic acid: role of the butyryl group. |
2004 |
Oncol. Rep. |
pmid:14767528
|
Wu DS et al. |
Epigallocatechin-3-gallate and trichostatin A synergistically inhibit human lymphoma cell proliferation through epigenetic modification of p16INK4a. |
2013 |
Oncol. Rep. |
pmid:24064951
|
Shao G et al. |
Inactivation of EGFR/AKT signaling enhances TSA-induced ovarian cancer cell differentiation. |
2017 |
Oncol. Rep. |
pmid:28393191
|
Nakajima S et al. |
Trichostatin A with adenovirus-mediated p53 gene transfer synergistically induces apoptosis in breast cancer cell line MDA-MB-231. |
2009 |
Oncol. Rep. |
pmid:19513516
|
Zuo X et al. |
Breast cancer cells are arrested at different phases of the cell cycle following the re-expression of ARHI. |
2014 |
Oncol. Rep. |
pmid:24676336
|
Yanada M et al. |
Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines. |
2005 |
Oncol. Rep. |
pmid:16142337
|
Jia L et al. |
Trichostatin A increases radiosensitization of tongue squamous cell carcinoma via miR‑375. |
2017 |
Oncol. Rep. |
pmid:27878285
|
Zhang NH et al. |
Rejection of adenovirus infection is independent of coxsackie and adenovirus receptor expression in cisplatin-resistant human lung cancer cells. |
2016 |
Oncol. Rep. |
pmid:27373420
|
Kang HR et al. |
Butyrate-mediated acquisition of chemoresistance by human colon cancer cells. |
2016 |
Oncol. Rep. |
pmid:27277338
|
Qiao F et al. |
Enforced expression of RASAL1 suppresses cell proliferation and the transformation ability of gastric cancer cells. |
2012 |
Oncol. Rep. |
pmid:22825043
|
Liu Z et al. |
Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells. |
2008 |
Oncol. Rep. |
pmid:18575731
|
Wang SC et al. |
Trichostatin A induces bladder cancer cell death via intrinsic apoptosis at the early phase and Sp1‑survivin downregulation at the late phase of treatment. |
2017 |
Oncol. Rep. |
pmid:28713892
|
Puppin C et al. |
Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells. |
2011 |
Oncol. Rep. |
pmid:21152868
|
Androutsopoulos VP and Spandidos DA |
Antiproliferative effects of TSA, PXD‑101 and MS‑275 in A2780 and MCF7 cells: Acetylated histone H4 and acetylated tubulin as markers for HDACi potency and selectivity. |
2017 |
Oncol. Rep. |
pmid:29039546
|
Zhang X et al. |
Histone deacetylase inhibitor, trichostatin A, increases the chemosensitivity of anticancer drugs in gastric cancer cell lines. |
2006 |
Oncol. Rep. |
pmid:16865256
|
Villanueva R et al. |
Histone deacetylase 3 represses HTLV-1 tax transcription. |
2006 |
Oncol. Rep. |
pmid:16865259
|
Puppin C et al. |
Histone deacetylase inhibitors induce thymidine phosphorylase expression in cultured breast cancer cell lines. |
2011 |
Oncol. Rep. |
pmid:21617864
|
Seo JS et al. |
Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A. |
2008 |
Oncol. Rep. |
pmid:18097580
|
Meng CF et al. |
Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells. |
2009 |
Oncol. Rep. |
pmid:19787243
|
Tamannai M et al. |
The inhibitor of growth 1 (ING1) is involved in trichostatin A-induced apoptosis and caspase 3 signaling in p53-deficient glioblastoma cells. |
2010 |
Oncol. Res. |
pmid:20681406
|
Lin S et al. |
Silencing of ATP4B of ATPase H/K Transporting Beta Subunit by Intragenic Epigenetic Alteration in Human Gastric Cancer Cells. |
2017 |
Oncol. Res. |
pmid:28281974
|
Chiba T et al. |
Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells. |
2004 |
Oncology |
pmid:15452378
|
Maldonado L et al. |
An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine. |
2014 |
Oncotarget |
pmid:24980822
|
Wilson-Edell KA et al. |
RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth. |
2014 |
Oncotarget |
pmid:24970821
|
Chen L et al. |
PI3K/mTOR dual inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A synergistically exert anti-tumor activity in breast cancer. |
2017 |
Oncotarget |
pmid:28060760
|
Kikuchi M et al. |
Epigenetic regulation of ZEB1-RAB25/ESRP1 axis plays a critical role in phenylbutyrate treatment-resistant breast cancer. |
2016 |
Oncotarget |
pmid:26646320
|
Choi SA et al. |
A novel histone deacetylase inhibitor, CKD5, has potent anti-cancer effects in glioblastoma. |
2017 |
Oncotarget |
pmid:27852054
|
Piao J et al. |
Superior efficacy of co-treatment with the dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A against NSCLC. |
2016 |
Oncotarget |
pmid:27507059
|
Perez-Janices N et al. |
Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis. |
2015 |
Oncotarget |
pmid:26284587
|
Lee YR et al. |
Extracellularly secreted APE1/Ref-1 triggers apoptosis in triple-negative breast cancer cells via RAGE binding, which is mediated through acetylation. |
2015 |
Oncotarget |
pmid:26125438
|
Gan YH and Zhang S |
PTEN/AKT pathway involved in histone deacetylases inhibitor induced cell growth inhibition and apoptosis of oral squamous cell carcinoma cells. |
2009 |
Oral Oncol. |
pmid:19574087
|
Vanommeslaeghe K et al. |
Ab initio study of the binding of Trichostatin A (TSA) in the active site of histone deacetylase like protein (HDLP). |
2003 |
Org. Biomol. Chem. |
pmid:12968347
|
Chatterjee A et al. |
An efficient synthesis of (+/-)-trichostatic Acid and analogues: a new route to (+/-)-trichostatin A. |
2010 |
Org. Lett. |
pmid:20104892
|
Cosner CC and Helquist P |
Concise, convergent syntheses of (±)-trichostatin A utilizing a Pd-catalyzed ketone enolate α-alkenylation reaction. |
2011 |
Org. Lett. |
pmid:21688856
|
Liu Y and Li S |
A Cell Culture Model of Latent and Lytic Herpes Simplex Virus Type 1 Infection in Spiral Ganglion. |
2015 |
ORL J. Otorhinolaryngol. Relat. Spec. |
pmid:26022499
|
Nasu Y et al. |
Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model. |
2008 |
Osteoarthr. Cartil. |
pmid:18226559
|
Nayak S et al. |
Superior Versus Inferior Vestibular Neuritis: Are There Intrinsic Differences in Infection, Reactivation, or Production of Infectious Particles Between the Vestibular Ganglia? |
2015 |
Otol. Neurotol. |
pmid:25978655
|
Angst E et al. |
Epigenetic regulation affects N-myc downstream-regulated gene 1 expression indirectly in pancreatic cancer cells. |
2010 |
Pancreas |
pmid:20173668
|
Tiffon C |
Histone Deacetylase Inhibition Restores Expression of Hypoxia-Inducible Protein NDRG1 in Pancreatic Cancer. |
2018 |
Pancreas |
pmid:29303911
|
Mehdi O et al. |
HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA). |
2012 Mar-Apr |
Pancreatology |
pmid:22487525
|
Mostafavi-Pour Z et al. |
Methylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer. |
2015 |
Pathol. Oncol. Res. |
pmid:25743258
|
Zhu L et al. |
Hyperoxia arrests alveolar development through suppression of histone deacetylases in neonatal rats. |
2012 |
Pediatr. Pulmonol. |
pmid:21905265
|
Nair S et al. |
Synergistic effects of a combination of dietary factors sulforaphane and (-) epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells. |
2008 |
Pharm. Res. |
pmid:17657594
|
Maleszewska M et al. |
The effects of selected inhibitors of histone modifying enzyme on C6 glioma cells. |
2014 |
Pharmacol Rep |
pmid:24905315
|
Xie C et al. |
In vitro analysis of factors influencing expression as potential determinants of interindividual variation. |
2017 |
Pharmacol Res Perspect |
pmid:28357125
|
Wang BY et al. |
Epigenetic suppression of hippocampal BDNF mediates the memory deficiency induced by amyloid fibrils. |
2014 |
Pharmacol. Biochem. Behav. |
pmid:25242807
|
Yao J et al. |
NF-kappaB signaling pathway is involved in growth inhibition, G2/M arrest and apoptosis induced by Trichostatin A in human tongue carcinoma cells. |
2006 |
Pharmacol. Res. |
pmid:17005413
|
Bartoli A et al. |
Effect of trichostatin a and 5'-azacytidine on transgene reactivation in U937 transduced cells. |
2003 |
Pharmacol. Res. |
pmid:12770523
|
Chen J and Kang JH |
Quercetin and trichostatin A cooperatively kill human leukemia cells. |
2005 |
Pharmazie |
pmid:16320950
|
Chen HY et al. |
Histone deacetylase inhibitors trichostatin A and suberoylanilide hydroxamic acid attenuate ventilator-induced lung injury. |
2014 |
Pharmazie |
pmid:24601225
|
Chen J et al. |
Trichostatin A improves the anticancer activity of low concentrations of curcumin in human leukemia cells. |
2006 |
Pharmazie |
pmid:16964716
|
Jia J and Chen J |
Histone hyperacetylation is involved in the quercetin-induced human leukemia cell death. |
2008 |
Pharmazie |
pmid:18557424
|
Ogura A et al. |
Recent advancements in cloning by somatic cell nuclear transfer. |
2013 |
Philos. Trans. R. Soc. Lond., B, Biol. Sci. |
pmid:23166393
|
Pollack BP et al. |
Ultraviolet radiation-induced transcription is associated with gene-specific histone acetylation. |
2009 May-Jun |
Photochem. Photobiol. |
pmid:19076306
|
Krause M et al. |
Probing the compressibility of tumor cell nuclei by combined atomic force-confocal microscopy. |
2013 |
Phys Biol |
pmid:24304807
|
Zhang L et al. |
ABA treatment of germinating maize seeds induces VP1 gene expression and selective promoter-associated histone acetylation. |
2011 |
Physiol Plant |
pmid:21679193
|
Miller L et al. |
Histone deacetylase 1 (HDAC1) participates in the down-regulation of corticotropin releasing hormone gene (crh) expression. |
2011 |
Physiol. Behav. |
pmid:21463644
|
Majumdar G et al. |
Panhistone deacetylase inhibitors inhibit proinflammatory signaling pathways to ameliorate interleukin-18-induced cardiac hypertrophy. |
2011 |
Physiol. Genomics |
pmid:21954451
|
Peltonen K et al. |
Melanoma cell lines are susceptible to histone deacetylase inhibitor TSA provoked cell cycle arrest and apoptosis. |
2005 |
Pigment Cell Res. |
pmid:15892716
|
Schwahn DJ et al. |
Dynamic regulation of the human dopachrome tautomerase promoter by MITF, ER-alpha and chromatin remodelers during proliferation and senescence of human melanocytes. |
2005 |
Pigment Cell Res. |
pmid:15892717
|